Profiles: Witnesses | Back to Witnesses List
Albino, Anthony
US Fact Witness
Dr. Albino is currently Vice President of Public Health Affairs at the Vector Group. His employment with Vector Tobacco began in March 2001, but was transferred in the spring of 2002 to work for the Vector Group, Ltd. Both Vector Tobacco and Vector Group, Ltd. are affiliated with the Liggett Group Inc. Dr. Albino received his Ph.D. from Cornell University in 1974 in retrovirology. Following a postdoctoral fellowship, Dr. Albino was employed as a researcher at the Hospital for Special Surgery (1974-78), Memorial Sloan-Kettering Cancer Center (1978-1995), and then Director of Research at the Manhattan Eye, Ear, and Throat Hospital (1995-1997). He was then Director of Research at the American Health Foundation (1997-2201). Dr. Albino was hired to research the feasability of developing a reduced carcinogen cigarette that may reduce the risk of adverse health effects from smoking. Dr. Albino supervises all aspects of Vector's research efforts with respect to the biological effects of its reduced carcinogen cigarette, Omni. He is knowledgeable of the fact that Vector conducted no biological testing of Omni prior to marketing. Furthermore, Vector does not know, based upon its research, whether Omni is less carcinogenic, genotoxic or mutagenic than control cigarettes.
Source: United States' Factual Memorandum Pursuant to Order #470, Section V (tab 1)